Inaugural session – organised by the China Organising Committee (I hour)
  • Ministers
  • ILA President
  • WHO Representative
  • ILEP President
  • Novartis Foundation
  • Nippon Foundation
  • China Association of People affected by leprosy

Special Presentation: 60 years of leprosy control in China - Professor Zhang Guocheng




Plenary 1: A Global strategy for leprosy fit for purpose (1.5 hours)

Chair: Marcos Virmond (ILA President, Brazil)

Special Keynote Lecture: The immune response at the site of infection in leprosy – Robert Modlin (USA)

WHO Global Strategy for Leprosy 2016-2020: accelerating towards a leprosy-free world – Drs Erwin Cooremanand Laura Gillini(25 minutes)

Discussants:  Fit for national government (India)
                          Fit with national government (Brazil) - Rosa Castalia
                          Fit with NGOs – Tanya Wood (ILEP)
                          Fit with needs of people affected leprosy – V Narsappa (APAL-India)
                          Fit with NTDs – Emmy van der Grinten (Ghana)

Moderated Discussion: 30 minutes




Plenary 2: Innovations to reduce transmission (1.5hours)

Chair: Ann Aerts (Novartis Foundation)

What will U-MDT contribute to leprosy control? (JH Kawuma - Uganda)

The potential of chemoprophylaxis to reduce transmission (Peter Steinmann - Switzerland)

Can new diagnostic test improve control of leprosy?  (Fareed Mirza – Switzerland)

Can novel vaccines become a reality? (Steve Reed - USA)

Moderated Discussion: 30 minutes



Plenary 3: Advances in clinical management of leprosy

Chair: Shyamala Anand - Clinical Ophthalmologist (India)

Understanding the pathology of nerve injury in leprosy - Sergio L Antunes (Brazil)

Advances in dermatological aspects of leprosy - Fu Ren Zhang (China)

Advances in the treatment of reactions - Diana Lockwood (UK)

Integrated preventing disability across NTDs - Linda Lehman (Brazil)

Moderated Discussion: 30 minutes



Plenary 4:  Promoting inclusion of people affected by leprosy

Chair: Anwei Law (USA)

Sociological aspects of barriers and facilitators to inclusion - Cassandra White (USA)

Evidence for interventions to reduce stigma - Ruth Peters (Indonesia)

Enabling participation of people affected by leprosy - Michael Chen (HANDA, China)

Making a difference to policy and practice - Matthias Duck (Paraguay)

Moderated Discussion: 30 minutes



Copyright © CICCST, 2010-2014